Literature DB >> 24142151

Functional pathways altered after silencing Pnpla6 (the codifying gene of neuropathy target esterase) in mouse embryonic stem cells under differentiation.

David Pamies1, Eugenio Vilanova, Miguel A Sogorb.   

Abstract

Neuropathy target esterase (NTE) is involved in several disorders in adult organisms and embryos. A relationship between NTE and nervous system integrity and maintenance in adult systems has been suggested. NTE-related motor neuron disease is associated with the expression of a mutant form of NTE and the inhibition and further modification of NTE by organophosphorus compounds is the trigger of a delayed neurodegenerative neuropathy. Homozygotic NTE knockout mice embryos are not viable, while heterozygotic NTE knockout mice embryos yields mice with neurological disorders, which suggest that this protein plays a critical role in embryonic development. The present study used D3 mouse embryonic stem cells with the aim of gaining mechanistic insights on the role of Pnpla6 (NTE gene encoding) in the developmental process. D3 cells were silenced by lipofectamine transfection with a specific interference RNA for Pnpla6. Silencing Pnpla6 in D3 monolayer cultures reduced NTE enzymatic activity to 50% 20 h post-treatment, while the maximum loss of Pnpla6 expression reached 80% 48 h postsilencing. Pnpla6 was silenced in embryoid bodies and 545 genes were differentially expressed regarding the control 96 h after silencing, which revealed alterations in multiple genetic pathways, such as cell motion and cell migration, vesicle regulation, and cell adhesion. These findings also allow considering that these altered pathways would impair the formation of respiratory, neural, and vascular tubes causing the deficiencies observed in the in vivo development of nervous and vascular systems. Our findings, therefore, support the previous observations made in vivo concerning lack of viability of mice embryos not expressing NTE and help to understand the biology of several neurological and developmental disorders in which NTE is involved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24142151     DOI: 10.1007/s11626-013-9691-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  47 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

Review 2.  Neurovascular development: The beginning of a beautiful friendship.

Authors:  Victoria L Bautch; Jennifer M James
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

3.  Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man.

Authors:  M J Lush; Y Li; D J Read; A C Willis; P Glynn
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

4.  Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.

Authors:  Shirley Rainier; James W Albers; Peter J Dyck; O Petter Eldevik; Sandra Wilcock; Rudy J Richardson; John K Fink
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

5.  Expression of Neuropathy Target Esterase in mouse embryonic stem cells during differentiation.

Authors:  David Pamies; Juan Antonio Reig; Eugenio Vilanova; Miguel A Sogorb
Journal:  Arch Toxicol       Date:  2010-01-30       Impact factor: 5.153

Review 6.  The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.

Authors:  F S Jones; P L Jones
Journal:  Dev Dyn       Date:  2000-06       Impact factor: 3.780

7.  Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity.

Authors:  Christopher J Winrow; Matthew L Hemming; Duane M Allen; Gary B Quistad; John E Casida; Carrolee Barlow
Journal:  Nat Genet       Date:  2003-03-17       Impact factor: 38.330

8.  Morphological effects of neuropathy-inducing organophosphorus compounds in primary dorsal root ganglia cell cultures.

Authors:  Christiane Massicotte; Bernard S Jortner; Marion Ehrich
Journal:  Neurotoxicology       Date:  2003-12       Impact factor: 4.294

9.  Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells.

Authors:  W Li; J E Casida
Journal:  Toxicol Lett       Date:  1998-09-15       Impact factor: 4.372

10.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868

View more
  4 in total

1.  Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.

Authors:  David Pamies; Miguel A Sogorb; Marco Fabbri; Laura Gribaldo; Angelo Collotta; Bibiana Scelfo; Eugenio Vilanova; Georgina Harris; Anna Bal-Price
Journal:  Int J Mol Sci       Date:  2014-01-09       Impact factor: 5.923

Review 2.  PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases.

Authors:  Doris Kretzschmar
Journal:  Metabolites       Date:  2022-03-24

3.  DNA Methylation of Patatin-Like Phospholipase Domain-Containing Protein 6 Gene Contributes to the Risk of Intracranial Aneurysm in Males.

Authors:  Shengjun Zhou; Junjun Zhang; Chenhui Zhou; Fanyong Gong; Xueli Zhu; Xingqiang Pan; Jie Sun; Xiang Gao; Yi Huang
Journal:  Front Aging Neurosci       Date:  2022-07-11       Impact factor: 5.702

4.  Analysis of the neurotoxic effects of neuropathic organophosphorus compounds in adult zebrafish.

Authors:  Melissa Faria; Inmaculada Fuertes; Eva Prats; Jose Luis Abad; Francesc Padrós; Cristian Gomez-Canela; Josefina Casas; Jorge Estevez; Eugenio Vilanova; Benjamin Piña; Demetrio Raldúa
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.